Tinea versicolor: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 14: Line 14:
}}
}}
__NOTOC__
__NOTOC__
{{SI}}
{{Dermatophytosis}}
 
{{CMG}}; {{AE}} {{KS}}
{{CMG}}; {{AE}} {{KS}}
==Overview==
==Overview==


Revision as of 19:07, 11 August 2015

Tinea versicolor
ICD-10 B36.0
ICD-9 111.0
DiseasesDB 10071
MedlinePlus 001465
eMedicine derm/423 

Dermatophytosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Dermatophytosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiographic Findings

X-Ray Findings

CT scan Findings

MRI Findings

Ultrasound Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Tinea versicolor On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tinea versicolor

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onTinea versicolor

CDC on Tinea versicolor

Tinea versicolor in the news

Blogs on Tinea versicolor

Directions to Hospitals Treating Dermatophytosis here

Risk calculators and risk factors for Tinea versicolor

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

Overview

Tinea versicolor or pityriasis versicolor is a common skin infection caused by the yeast Malassezia furfur (formerly termed Pityrosporum ovale). This yeast is normally found on the human skin and only becomes troublesome under certain circumstances, such as a warm and humid environment.

Symptoms

The symptoms of this condition include:

  • Generally oval or irregularly-shaped spots of 1/4 to 1 inch in diameter, often merging together to form a larger patch
  • Occasional fine scaling of the skin producing a very superficial ash-like scale
  • Pale, dark tan, or pink in color, with a reddish undertone that can darken when the patient is overheated, such as in a hot shower or during/after exercise
  • Sharp border

These spots commonly affect the back, underarm, upper arm, chest, lower legs, and neck. Occasionally it can also be present on the face. The yeasts can often be seen under the microscope within the lesions and typically have a so called "spaghetti and meat ball appearance" as the round yeasts produce filaments.

In people with dark skin tones, pigmentary changes such as hypopigmentation (loss of color) are common, while in those with lighter skin color, hyperpigmentation (increase in skin color) are more common. These discolorations have led to the term "sun fungus".

Diagnosis

Physical Examination

Skin

Trunk
Extremities

Prevalence

Tinea versicolor is a common condition. It is estimated that 2 to 8% of the population of the United States has it. This skin disease commonly affects adolescents and young adults, especially in warm and humid climates. It is thought that the yeast feeds on skin oils (lipids) as well as dead skin cells.


Tinea Versicolor

Treatment

Treatments for tinea versicolor include:

  • Topical antifungal medications - containing either 2.5% selenium sulfide (Selsun® shampoo in UK, but not Selsun Blue which contains only 1%) or 2% ketoconazole (Nizoral® ointment and shampoo) applied to dry skin and washed off after 10 minutes, repeated daily for 2 weeks. Other topical antifungal agents such as clotrimazole, miconazole or terbinafine are less widely recommended. Additionally, hydrogen peroxide has been known to lessen symptoms, and on certain occasions, remove the problem.
  • Oral antifungal prescription only medications include 400 mg of ketoconazole or fluconazole in a single dose, or ketoconazole 200 mg daily for 7 days, or itraconazole 400 mg daily for 3-7 days. The single-dose regimens can be made more effective by having the patient exercise 1-2 hours after the dose, to induce sweating. The sweat is allowed to evaporate, and showering is delayed for a day, leaving a film of the medication on the skin.
  • Recurrence is common and may be reduced by intermittent application of topical agents (such as tea tree oil) or adding a small amount of anti-dandruff shampoo to water used for bathing.

Antimicrobial Regimen

  • Tinea versicolor[2]
  • Preferred regimen: Ketoconazole 400 mg PO single dose OR 200 mg q24h for 7 days OR 2% cream once q24h for 2 weeks
  • Alternative regimen: Fluconazole 400 mg PO single dose OR Itraconazole 400 mg PO q24h for 3–7 days

External links

References

  1. ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 1.21 1.22 1.23 1.24 1.25 1.26 1.27 1.28 1.29 1.30 1.31 1.32 1.33 1.34 1.35 1.36 1.37 1.38 1.39 1.40 1.41 1.42 1.43 1.44 1.45 1.46 1.47 1.48 1.49 1.50 1.51 1.52 1.53 1.54 1.55 1.56 1.57 1.58 1.59 1.60 1.61 1.62 "Dermatology Atlas".
  2. ↑ Gilbert, David (2015). The Sanford guide to antimicrobial therapy. Sperryville, Va: Antimicrobial Therapy. ISBN 978-1930808843.

Template:Mycoses sv:Pityriasis versicolor sr:Tinea_versicolor

Template:WH Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Tinea_versicolor&oldid=1130311"